Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nestle S.A.
DescriptionRecombinant human insulin delivered using Natreon's Natsom drug delivery platform
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today